Tuesday, August 5, 2008

The Business Model Designed by Pharmaceutical Companies

(Are You Really Getting the Truth behind Cholesterol Lowering Drugs? If Not, This Is the Perfect Time to Read this Piece (Part-3) continued from Part-2)

The National Cholesterol Education Program (NCEP) announced a forged resolution about cholesterol lowering drugs. The former class of cholesterol lowering drugs is referred to as ‘fibrates’, while the newer known as ‘statins’. Consider it from the perspective of pharmaceutical companies. Isn’t it really great to make normal healthy people to patient in order to increase business for them? So their proposed business model is a 3 point business model – 1st point: the problem, which is cholesterol; 2nd point: state of reaction and 3rd point: treatment, which is cholesterol lowering drugs. Do you know that statin drugs are most extensively purchased pharmaceutical drugs in the history of medical science?